These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 23792198)

  • 1. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.
    Chang C; Lang H; Geng N; Wang J; Li N; Wang X
    Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
    Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
    FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.
    Chistiakov DA; Chistiakov AA
    Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
    Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
    Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes from patients with Parkinson's disease are pathological in mice.
    Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T
    J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
    Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
    Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
    Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
    Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia as modulators of exosomal alpha-synuclein transmission.
    Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
    Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
    Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH
    J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
    Sato H; Kato T; Arawaka S
    Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
    Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y
    CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity.
    Hu Z; Wang W; Ling J; Jiang C
    Cell Mol Neurobiol; 2016 Jul; 36(5):811-20. PubMed ID: 27002719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular α-synuclein--a possible initiator of inflammation in Parkinson's disease.
    Ren WQ; Tian ZM; Yin F; Sun JZ; Zhang JN
    Pharmazie; 2016 Feb; 71(2):51-5. PubMed ID: 27004367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of alpha-synuclein in Parkinson's disease].
    Miklya I; Pencz N; Hafenscher F; Göltl P
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):77-84. PubMed ID: 24978050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
    Zhang QS; Heng Y; Yuan YH; Chen NH
    Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression.
    Fan Y; Limprasert P; Murray IV; Smith AC; Lee VM; Trojanowski JQ; Sopher BL; La Spada AR
    Hum Mol Genet; 2006 Oct; 15(20):3002-11. PubMed ID: 16959793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes.
    Bliederhaeuser C; Grozdanov V; Speidel A; Zondler L; Ruf WP; Bayer H; Kiechle M; Feiler MS; Freischmidt A; Brenner D; Witting A; Hengerer B; Fändrich M; Ludolph AC; Weishaupt JH; Gillardon F; Danzer KM
    Acta Neuropathol; 2016 Mar; 131(3):379-91. PubMed ID: 26576561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.